021-51111890
购物车（0）
sales@molnova.cn
BMS-212122
CAS No. 194213-64-4
BMS-212122 ( —— )
产品货号. M34524 CAS No. 194213-64-4
BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥4522 | 有现货 |
|
| 5MG | ￥6686 | 有现货 |
|
| 10MG | ￥9125 | 有现货 |
|
| 25MG | ￥12434 | 有现货 |
|
| 50MG | ￥15484 | 有现货 |
|
| 100MG | ￥19125 | 有现货 |
|
| 500MG | ￥37485 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BMS-212122
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.
-
产品描述BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点CETP
-
受体CETP
-
研究领域——
-
适应症——
化学信息
-
CAS Number194213-64-4
-
分子量754.76
-
分子式C43H36F6N4O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(NCC(F)(F)F)(=O)C1(CCCCN2C=3C(N=C2C)=C(NC(=O)C4=C(C=CC=C4)C5=CC=C(C(F)(F)F)C=C5)C(C)=CC3)C=6C(C=7C1=CC=CC7)=CC=CC6
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
